CN104203212A - 味道掩蔽的分散性片剂 - Google Patents

味道掩蔽的分散性片剂 Download PDF

Info

Publication number
CN104203212A
CN104203212A CN201380016565.2A CN201380016565A CN104203212A CN 104203212 A CN104203212 A CN 104203212A CN 201380016565 A CN201380016565 A CN 201380016565A CN 104203212 A CN104203212 A CN 104203212A
Authority
CN
China
Prior art keywords
tablet
taste
exchange resin
cation exchange
drug
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201380016565.2A
Other languages
English (en)
Chinese (zh)
Inventor
V·K·阿罗拉
J·库拉那
D·盖克维德
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ranbaxy Laboratories Ltd
Original Assignee
Ranbaxy Laboratories Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ranbaxy Laboratories Ltd filed Critical Ranbaxy Laboratories Ltd
Publication of CN104203212A publication Critical patent/CN104203212A/zh
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/194—Carboxylic acids, e.g. valproic acid having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/58—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
    • A61K47/585—Ion exchange resins, e.g. polystyrene sulfonic acid resin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CN201380016565.2A 2012-02-21 2013-02-21 味道掩蔽的分散性片剂 Pending CN104203212A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IN496DE2012 2012-02-21
IN496/DEL/2012 2012-02-21
PCT/IB2013/051432 WO2013124818A1 (en) 2012-02-21 2013-02-21 Taste masked dispersible tablets

Publications (1)

Publication Number Publication Date
CN104203212A true CN104203212A (zh) 2014-12-10

Family

ID=54261187

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201380016565.2A Pending CN104203212A (zh) 2012-02-21 2013-02-21 味道掩蔽的分散性片剂

Country Status (10)

Country Link
US (1) US20150031647A1 (https=)
EP (1) EP2816997A1 (https=)
CN (1) CN104203212A (https=)
AP (1) AP2014007934A0 (https=)
AU (1) AU2013223705A1 (https=)
CA (1) CA2865312A1 (https=)
IN (1) IN2014DN07895A (https=)
MX (1) MX2014010038A (https=)
SG (1) SG11201405053SA (https=)
WO (1) WO2013124818A1 (https=)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106659792A (zh) * 2014-05-08 2017-05-10 西梯茜生命工学股份有限公司 含氯丙咪嗪的遮味口服药物制剂
CN112353802A (zh) * 2020-11-26 2021-02-12 山东诚创蓝海医药科技有限公司 一种富马酸伏诺拉生掩味组合物及其应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020032245A1 (en) 2000-07-27 2002-03-14 Lyn Hughes Resinate composition
US20040067216A1 (en) 2002-02-22 2004-04-08 Karki Shyam B. Hiv protease inhibitors supported on cation exchange resins for oral administration
EP2198857A1 (en) * 2008-12-19 2010-06-23 Ratiopharm GmbH Oral dispersible tablet
AU2010337856A1 (en) * 2009-12-31 2012-07-19 Ranbaxy Laboratories Limited Taste masked dosage forms of bitter tasting anti-retroviral drugs

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106659792A (zh) * 2014-05-08 2017-05-10 西梯茜生命工学股份有限公司 含氯丙咪嗪的遮味口服药物制剂
CN106659792B (zh) * 2014-05-08 2020-04-28 西梯茜生命工学股份有限公司 含氯丙咪嗪的遮味口服药物制剂
CN112353802A (zh) * 2020-11-26 2021-02-12 山东诚创蓝海医药科技有限公司 一种富马酸伏诺拉生掩味组合物及其应用

Also Published As

Publication number Publication date
SG11201405053SA (en) 2014-09-26
WO2013124818A1 (en) 2013-08-29
IN2014DN07895A (https=) 2015-04-24
EP2816997A1 (en) 2014-12-31
MX2014010038A (es) 2014-12-05
AP2014007934A0 (en) 2014-09-30
CA2865312A1 (en) 2013-08-29
AU2013223705A1 (en) 2014-09-11
US20150031647A1 (en) 2015-01-29

Similar Documents

Publication Publication Date Title
TWI838340B (zh) 含有沃諾拉贊的製劑
JP2023063386A (ja) シロドシンの苦味をマスキングした経口投与製剤
AU2003209673B2 (en) Tasteless directly compressible fast-dissolving complexes and pharmaceutical formulations thereof
WO2011019043A1 (ja) ２種以上の粒子を含有する口腔内速崩壊錠
KR102082775B1 (ko) 수용해도 및 생체이용율이 개선된 조성물
HUP0201307A2 (hu) Ízfedett gyógyszerkészítmények
CN106999600A (zh) 包含粉碎乳糖或制粒乳糖的崩解性颗粒组合物
JP2001270821A (ja) 服用感が優れた散剤
CN104203212A (zh) 味道掩蔽的分散性片剂
ES2622568T3 (es) Comprimido que contiene 5-hidroxi-1H-imidazol-4-carboxamida
CN104248626B (zh) 左乙拉西坦泡腾干混悬剂及其制备方法
CN105287413A (zh) 一种含有孟鲁司特钠的咀嚼片及其制备方法
TWI644688B (zh) 含有崩解性粒子組成物之口腔內崩解錠劑之製造方法
CA2785622A1 (en) Taste masked dosage forms of bitter tasting anti-retroviral drugs
TW201315462A (zh) 異丁苯丙酸可嚼錠
CN104771375A (zh) 一种盐酸决奈达隆片剂及其制备方法
EP3050575B1 (en) Disintegrating particle composition produced by two-stage wet granulation process, and intraorally disintegrating tablet containing same composition
JP5615554B2 (ja) ３−｛５−［４−（シクロペンチルオキシ）−２−ヒドロキシベンゾイル］−２−［（３−ヒドロキシ−１，２−ベンズイソオキサゾール−６−イル）メトキシ］フェニル｝プロピオン酸またはその塩を含有する固体分散体の組成物
AU2003214504A1 (en) Taste masked compositions of erythromycin a and derivatives thereof
CN103169706B (zh) 一种含有对乙酰氨基酚和右美沙芬的复方口腔崩解片
JP7058104B2 (ja) アプレピタントを有効成分とする医薬錠剤
JP2000273037A (ja) 解熱・鎮痛チュアブル錠およびその製造法
JP2683454B2 (ja) 固形制酸剤及びその製造法
CN104248625A (zh) 阿伐那非泡腾干混悬剂及其制备方法
OA17084A (en) Taste masked dispersible tablets.

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20141210